← FDA DRUG APPROVALS

FDA ANDA · ANDA200791

MECLIZINE HYDROCHLORIDE

Sponsor: INVAGEN PHARMS

APPLICATION
ANDA200791
TYPE
ANDA
ORIGINAL APPROVAL
2022-02-17
LATEST ACTION
2022-02-17
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Discontinued

Products

MECLIZINE HYDROCHLORIDEDiscontinued
MECLIZINE HYDROCHLORIDE 25MG · TABLET, CHEWABLE · ORAL

Approval history

2022-02-17Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →